GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) Earnings Call Analysis
NYSE · Unknown · Unknown
Earnings Reports
-
GSK (GSK) Q2 2026: £1.9B Cost Program Accelerates 20+ Phase 3 Trials, Margin Outlook Lifts
July 29, 2026
-
GSK (GSK) Q1 2026: Specialty Medicines Surge 14%, Pipeline Acceleration Signals Portfolio Pivot
July 26, 2026
-
GSK (GSK) Q4 2025: Specialty Medicines Jump 17% as Pipeline Acceleration and Product Focus Take Hold
June 15, 2026
-
GSK (GSK) Q3 2025: Specialty Medicines Jump 16%, Pipeline and Margin Leverage Drive 2026 Confidence
October 29, 2025